Malaria research and its influence on anti-malarial drug policy in Malawi: a case study

BACKGROUND: In 1993, Malawi changed its first-line anti-malarial treatment for uncomplicated malaria from chloroquine to sulfadoxine-pyrimethamine (SP), and in 2007, it changed from SP to lumefantrine-artemether. The change in 1993 raised concerns about whether it had occurred timely and whether it...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwendera, Chikondi, de Jager, Christiaan, Longwe, Herbert, Phiri, Kamija, Hongoro, Charles, Mutero, Clifford M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888534/
https://www.ncbi.nlm.nih.gov/pubmed/27246503
http://dx.doi.org/10.1186/s12961-016-0108-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888534/
https://www.ncbi.nlm.nih.gov/pubmed/27246503
http://dx.doi.org/10.1186/s12961-016-0108-1

Ejemplares similares